A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors
Clinical trial NCT07446725 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07446725
- Sponsor
- Suzhou Genhouse Bio Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-24
- Primary completion
- 2029-10-30
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.